Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

1.

An orthogonal C-H borylation--cross-coupling strategy for the preparation of tetrasubstituted "A2B2"-chrysene derivatives with tuneable photophysical properties.

Heard KW, Morrison JJ, Weston L, Lo CH, Pirvu L, Raftery J, Little MS, McDouall JJ, Yeates SG, Quayle P.

Chem Commun (Camb). 2015 Apr 11;51(28):6115-8. doi: 10.1039/c4cc10132d.

PMID:
25745672
2.
3.

Synthesis of l-Iduronic Acid Derivatives via [3.2.1] and [2.2.2] l-Iduronic Lactones from Bulk Glucose-Derived Cyanohydrin Hydrolysis: A Reversible Conformationally Switched Superdisarmed/Rearmed Lactone Route to Heparin Disaccharides.

Hansen SU, Dalton CE, BarĂ¡th M, Kwan G, Raftery J, Jayson GC, Miller GJ, Gardiner JM.

J Org Chem. 2015 Apr 17;80(8):3777-89. doi: 10.1021/jo502776f. Epub 2015 Apr 7.

PMID:
25646641
4.

Antibacterial activities of novel nicotinic acid hydrazides and their conversion into N-acetyl-1,3,4-oxadiazoles.

Morjan RY, Mkadmh AM, Beadham I, Elmanama AA, Mattar MR, Raftery J, Pritchard RG, Awadallah AM, Gardiner JM.

Bioorg Med Chem Lett. 2014 Dec 15;24(24):5796-800. doi: 10.1016/j.bmcl.2014.10.029. Epub 2014 Oct 24.

PMID:
25454271
5.

Health economic evaluation in England.

Raftery J.

Z Evid Fortbild Qual Gesundhwes. 2014;108(7):367-74. doi: 10.1016/j.zefq.2014.08.019. Epub 2014 Sep 22.

PMID:
25444294
6.

Reforming the cancer drug fund.

Buxton M, Longworth L, Raftery J, Sculpher M, Towse A.

BMJ. 2014 Nov 28;349:g7276. doi: 10.1136/bmj.g7276. No abstract available.

PMID:
25432928
7.

Designing foldamer-foldamer interactions in solution: the roles of helix length and terminus functionality in promoting the self-association of aminoisobutyric acid oligomers.

Pike SJ, Diemer V, Raftery J, Webb SJ, Clayden J.

Chemistry. 2014 Nov 24;20(48):15981-90. doi: 10.1002/chem.201403626. Epub 2014 Oct 3.

PMID:
25280242
8.

Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures.

Morgan JM, Dimitrov BD, Gill J, Kitt S, Ng GA, McComb JM, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Yao GL, Cowie MR.

Eur J Heart Fail. 2014 Sep;16(9):1039-45. doi: 10.1002/ejhf.149. Epub 2014 Aug 18.

PMID:
25136791
9.

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial.

Dakin HA, Wordsworth S, Rogers CA, Abangma G, Raftery J, Harding SP, Lotery AJ, Downes SM, Chakravarthy U, Reeves BC; IVAN Study Investigators.

BMJ Open. 2014 Jul 29;4(7):e005094. doi: 10.1136/bmjopen-2014-005094.

10.

An Approach to the Synthesis of Functionalized Polycyclic Aromatic Hydrocarbons.

Little M, Lan H, Raftery J, Morrison JJ, McDouall JJ, Yeates SG, Quayle P.

European J Org Chem. 2013 Sep;2013(27):6038-6041. Epub 2013 Aug 9.

11.

Why there is no legal or medical justification for the Saatchi bill.

Raftery J, Newdick C.

BMJ. 2014 May 27;348:g3464. doi: 10.1136/bmj.g3464. No abstract available.

PMID:
24865354
12.

Conformational analysis of helical aminoisobutyric acid (Aib) oligomers bearing C-terminal ester Schellman motifs.

Pike SJ, Raftery J, Webb SJ, Clayden J.

Org Biomol Chem. 2014 Jun 28;12(24):4124-31. doi: 10.1039/c4ob00268g.

PMID:
24831537
13.

NICE's cost-effectiveness range: should it be lowered?

Raftery JP.

Pharmacoeconomics. 2014 Jul;32(7):613-5. doi: 10.1007/s40273-014-0158-6. No abstract available.

PMID:
24811892
14.

Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD.

McCann DC, Thompson M, Daley D, Barton J, Laver-Bradbury C, Hutchings J, Coghill D, Stanton L, Maishman T, Dixon L, Caddy J, Chorozoglou M, Raftery J, Sonuga-Barke E.

Trials. 2014 Apr 25;15:142. doi: 10.1186/1745-6215-15-142.

15.

Synthesis, structures, and optical properties of ruthenium(II) complexes of the tris(1-pyrazolyl)methane ligand.

Coe BJ, Helliwell M, Peers MK, Raftery J, Rusanova D, Clays K, Depotter G, Brunschwig BS.

Inorg Chem. 2014 Apr 7;53(7):3798-811. doi: 10.1021/ic500145r. Epub 2014 Mar 10.

PMID:
24611472
16.

Evidence based selection of commonly used RT-qPCR reference genes for the analysis of mouse skeletal muscle.

Thomas KC, Zheng XF, Garces Suarez F, Raftery JM, Quinlan KG, Yang N, North KN, Houweling PJ.

PLoS One. 2014 Feb 11;9(2):e88653. doi: 10.1371/journal.pone.0088653. eCollection 2014.

17.

Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding.

Cohen D, Raftery J.

BMJ. 2014 Feb 12;348:g1445. doi: 10.1136/bmj.g1445. No abstract available.

PMID:
24523379
18.

PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study.

Little P, Hobbs FD, Moore M, Mant D, Williamson I, McNulty C, Lasseter G, Cheng MY, Leydon G, McDermott L, Turner D, Pinedo-Villanueva R, Raftery J, Glasziou P, Mullee M; PRISM investigators.

Health Technol Assess. 2014 Jan;18(6):vii-xxv, 1-101. doi: 10.3310/hta18060.

19.

Value based pricing: can it work?

Raftery J.

BMJ. 2013 Oct 11;347:f5941. doi: 10.1136/bmj.f5941. No abstract available.

PMID:
24124158
20.

Health Technology Assessment in the UK.

Raftery J, Powell J.

Lancet. 2013 Oct 12;382(9900):1278-85. doi: 10.1016/S0140-6736(13)61724-9. Review.

PMID:
24120204
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk